Literature DB >> 1524063

Association between formulary strategies and hospital drug expenditures.

T K Hazlet1, T W Hu.   

Abstract

National survey data were analyzed to determine whether an association existed between formulary strategies and hospital drug expenditures. Data on community hospitals were obtained from (1) ASHP's 1987 national survey of pharmaceutical services, (2) the American Hospital Association, and (3) the Health Care Financing Administration. Along with size, case mix, and salary information, data were collected on whether the hospitals used a well-controlled formulary, whether they used therapeutic interchange, and how much money they spent on drugs. A logarithmic cost-function model was used to obtain a straight-line equation that expressed the relationships between drug cost per patient day and the other variables assessed. Summary statistics were calculated with data from 514 hospitals. The adjusted coefficient of multiple determination indicated that the model was able to explain 24.6% of the observed variation in drug cost per patient day. A significant association was found between decreased costs and a well-controlled formulary, therapeutic interchange, or both. Hospitals that used either strategy spent 10.7% less for drugs than those that used neither. Hospitals that used both strategies spent 13.4% less than those that used neither. Analysis of national survey data suggests that use of a well-controlled formulary, therapeutic interchange, or both are associated with lower pharmacy drug expenditures.

Entities:  

Mesh:

Year:  1992        PMID: 1524063

Source DB:  PubMed          Journal:  Am J Hosp Pharm        ISSN: 0002-9289


  12 in total

1.  The effects of acquisition cost and budget-based compensation on the attitudes of pharmacy directors toward the adoption of a cost-effective new drug.

Authors:  M Kolassa; M C Smith; B F Banahan; D D Garner; W F Shughart
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

2.  High technology drugs for cancer: the decision process for adding to a formulary.

Authors:  J L Glennie; D M Woloschuk; K W Hall
Journal:  Pharmacoeconomics       Date:  1993-12       Impact factor: 4.981

3.  Determinants of hospital drug expenditures in Western Europe.

Authors:  P Thürmann; S Harder
Journal:  Pharmacoeconomics       Date:  1993-09       Impact factor: 4.981

Review 4.  Formulary management of macrolide antibiotics.

Authors:  D R Guay
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

5.  Factors that influence patient response to requests to change to a unified restrictive formulary.

Authors:  Gerald W Smetana; Roger B Davis; Russell S Phillips
Journal:  J Gen Intern Med       Date:  2004-12       Impact factor: 5.128

6.  The role of pharmacoeconomics in formulary decision making in different hospitals in Riyadh, Saudi Arabia.

Authors:  Mohammed S Alsultan
Journal:  Saudi Pharm J       Date:  2010-11-04       Impact factor: 4.330

7.  Strategies for controlling antibiotic use in a tertiary-care paediatric hospital.

Authors:  S A Diamond; B J Hales
Journal:  Paediatr Child Health       Date:  1997-05       Impact factor: 2.253

8.  [Structure and activities of drug committees in Germany. Results of a survey of 143 hospitals. Pharmaco-economic Study Group and Rational Drug Therapy of the German Society of Clinical Pharmacology and Therapy].

Authors:  S Harder; P Thürmann; A Steioff
Journal:  Med Klin (Munich)       Date:  1998-02-15

9.  Approaches to rationing drugs in hospitals. An Australian perspective.

Authors:  F Bochner; N G Burgess; E D Martin
Journal:  Pharmacoeconomics       Date:  1996-11       Impact factor: 4.981

Review 10.  Constraints on antidepressant prescribing and principles of cost-effective antidepressant use. Part 1: Depression and its treatment.

Authors:  J A Henry; C A Rivas
Journal:  Pharmacoeconomics       Date:  1997-05       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.